| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.093 | 0.07 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.07 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |